We then performed microarray datasets downloaded from GEO (GSE20194, GSE20271 and GSE25055) to further define the value of SCD5 in curative effect assessment of anthracycline/taxane-based NACT for breast cancer. The gene discussed is SCD5; the disease is breast cancer.